Human LILRA2/CD85h/LIR7/ILT1 Gene, Full-length cDNA Clone in Lentivector, Endotoxin-free DNA
LILRA2 (Leukocyte immunoglobulin like receptor A2), also known as CD85H and LIR7 (Leukocyte immunoglobulin-like receptor 7), is a member of the leukocyte immunoglobulin (Ig)-like receptor (LIR) family of the Ig superfamily (IgSF). LIR family members are known to have activating and inhibitory functions in leukocytes. It belongs to the subfamily A class of LIR receptors (LILRAs), which are single-pass type I transmembrane proteins with 2-4 extracellular Ig-like domains, a transmembrane domain (TM), and a short cytoplasmic tail. LILRA2 contains 4 Ig-like C2 type domains in the extracellular region. LILRA2 does not bind class I MHC antigens. LILRA2 is expressed predominantly on monocytes and B cells, and at lower levels on dendritic cells and natural killer cells. LILRA2 is an activating receptor that inhibits dendritic cell differentiation and antigen presentation and suppresses innate immune response.
Gene Symbol: LILRA2; LIR7; CD85H; LIR-7; ILT1; ILT-1
NCBI Gene ID: 11027
Uniprot Entry: Q8N149
Construct Details: Full length human LILRA2 gene is subcloned into the Lentiviral expression vector pLTC with an upstream CMV promoter, which can be used for both transient and stable expression in mammalian cells. It can be co-transfected with the LentiPAK DNA mix (SKU# LP-001) into HEK293 cells to produce high titer lentiviral particles.
Vector Type: pLTC (lentiviral expression vector containing a heterologous CMV promoter and with or without a marker, see the vector map above)
Formulation: Supplied with 10 μg of endotoxin-free plasmid DNA at 200 ng/μl in sterile TE buffer (pH8.0)
Gene Insert Size: 1452 (bp)
Gene Insert Sequence:
ATGACCCCCATCCTCACGGTCCTGATCTGTCTCGGGCTGAGTCTGGGCCCCAGGACCCACGTGCAGGCAG
GGCACCTCCCCAAGCCCACCCTCTGGGCTGAGCCAGGCTCTGTGATCATCCAGGGAAGTCCTGTGACCCT
CAGGTGTCAGGGGAGCCTTCAGGCTGAGGAGTACCATCTATATAGGGAAAACAAATCAGCATCCTGGGTT
AGACGGATACAAGAGCCTGGGAAGAATGGCCAGTTCCCCATCCCATCCATCACCTGGGAACACGCAGGGC
GGTATCACTGTCAGTACTACAGCCACAATCACTCATCAGAGTACAGTGACCCCCTGGAGCTGGTGGTGAC
AGGAGCCTACAGCAAACCCACCCTCTCAGCTCTGCCCAGCCCTGTGGTGACCTCAGGAGGGAACGTGACC
CTCCAGTGTGTCTCACAGGTGGCATTTGACGGCTTCATTCTGTGTAAGGAAGGAGAAGATGAACACCCAC
AACGCCTGAACTCCCATTCCCATGCCCGTGGGTGGTCCTGGGCCATCTTCTCCGTGGGCCCCGTGAGCCC
GAGTCGCAGGTGGTCGTACAGGTGCTATGCTTATGACTCGAACTCTCCCTATGTGTGGTCTCTACCCAGT
GATCTCCTGGAGCTCCTGGTCCCAGGTGTTTCTAAGAAGCCATCACTCTCAGTGCAGCCAGGTCCTATGG
TGGCCCCTGGGGAGAGCCTGACCCTCCAGTGTGTCTCTGATGTCGGCTACGACAGATTTGTTCTGTATAA
GGAGGGAGAACGTGACTTCCTCCAGCGCCCTGGTTGGCAGCCCCAGGCTGGGCTCTCCCAGGCCAACTTC
ACCCTGGGCCCTGTGAGCCCCTCCCACGGGGGCCAGTACAGATGCTACAGTGCACACAACCTCTCCTCCG
AGTGGTCGGCCCCCAGTGACCCCCTGGACATCCTGATCACAGGACAGTTCTATGACAGACCCTCTCTCTC
GGTGCAGCCGGTCCCCACAGTAGCCCCAGGAAAGAACGTGACCCTGCTGTGTCAGTCACGGGGGCAGTTC
CACACTTTCCTTCTGACCAAGGAGGGGGCAGGCCATCCCCCACTGCATCTGAGATCAGAGCACCAAGCTC
AGCAGAACCAGGCTGAATTCCGCATGGGTCCTGTGACCTCAGCCCACGTGGGGACCTACAGATGCTACAG
CTCACTCAGCTCCAACCCCTACCTGCTGTCTCTCCCCAGTGACCCCCTGGAGCTCGTGGTCTCAGAAGCA
GCTGAGACCCTCAGCCCATCACAAAACAAGACAGACTCCACGACTACATCCCTAGGCCAACACCCCCAGG
ATTACACAGTGGAGAATCTCATCCGCATGGGTGTGGCTGGCTTGGTCCTGGTGGTCCTCGGGATTCTGCT
ATTTGAGGCTCAGCACAGCCAGAGAAGCCTACAAGATGCAGCCGGGAGGTGA
Primers: Gene insert coding sequence can be confirmed by following primers:
(a) forward (or 5'-end) primer: 5’-CAAATGGGCGGTAGGCGTG-3’;
(b) reverse (or 3'-end) primer: 5’-CCAGGTTTCCGGGCCCTCAC-3’
Note: The sequence may vary due to the naturally occurring variants or mutations, such as single nucleotide polymorphism, or the artifact during PCR amplification. High fidelity PCR systems should always be used.
FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.
Restriction: This product is not transferable or re-sellable. Customer obtain no right to transfer, assign, or sublicense its use rights, or to transfer, resell, package, or otherwise distribute the product, or to use the product for the benefit of any third party or for any commercial purpose. Customer may only use the product in compliance with applicable local, state and federal laws, regulations and rules. Customer may not directly or indirectly use the product or allow the transfer, transmission, export or re-export of all or any part of the product in violation of any export control law or regulation of the united states or any other relevant jurisdiction. Your use of this product constitutes acceptance of the terms of this limited use agreement. Please refer to our “terms & conditions” for details. If you are not willing to accept the limitation of this agreement, G&P Biosciences will accept return of the product for a full/partial refund.
The product is shipped at 4°C. Upon receipt, centrifuge the product briefly before opening the vial. It is recommended to store small aliquots at the temperature below –20°C for long-term storage and the product is stable for 6 months.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.
Additional supporting documents, including PDS, COA and MSDS are available upon request.
FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.
Restriction: This product is not transferable or re-sellable. Customer obtain no right to transfer, assign, or sublicense its use rights, or to transfer, resell, package, or otherwise distribute the product, or to use the product for the benefit of any third party or for any commercial purpose. Customer may only use the product in compliance with applicable local, state and federal laws, regulations and rules. Customer may not directly or indirectly use the product or allow the transfer, transmission, export or re-export of all or any part of the product in violation of any export control law or regulation of the united states or any other relevant jurisdiction. Your use of this product constitutes acceptance of the terms of this limited use agreement. Please refer to our “terms & conditions” for details. If you are not willing to accept the limitation of this agreement, G&P Biosciences will accept return of the product for a full/partial refund.